Form 4 for CVS CVS Health
Accepted 2026-05-11 17:27:40 ET · period of report 2026-05-08 · accession 0000064803-26-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 17:27 | 2026-05-08 | CVS | Mandadi Tilak | EVP, Chief Exp, Tech Off | S - Sale | $89.58 | -69.6K | 10.1K | -87% | -$6.23M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-08 | S | D | 69,551 | $89.58 | 10,133 | D | — | — | (F1) All shares sold at an Average price between $89.30 and $89.81. |